tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Similar Stocks

Compare
358 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Keros Therapeutics
$20.13
$634.61M
13.05
17.51%
3 Buy
4 Hold
0 Sell
Moderate Buy
Gyre Therapeutics
$7.35
$673.50M
192.91
-31.05%
3 Buy
0 Hold
0 Sell
Strong Buy
KalVista Pharmaceuticals
$15.00
$750.61M
-3.75
85.41%
9 Buy
0 Hold
0 Sell
Strong Buy
Palvella Therapeutics
$91.91
$1.09B
-7.63
702.00%
15 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$18.01
$1.85B
-6.07
-10.13%
14 Buy
2 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$17.64
$984.98M
-7.91
6.27%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KROS
Keros Therapeutics
20.13
3.10
18.20%
GYRE
Gyre Therapeutics
7.35
-3.79
-34.02%
KALV
KalVista Pharmaceuticals
15.00
6.64
79.43%
PVLA
Palvella Therapeutics
96.24
84.19
698.67%
NRIX
Nurix Therapeutics
18.01
-1.82
-9.18%
BCAX
Bicara Therapeutics Inc.
17.64
0.05
0.28%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts